The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hepatitis, Toxic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hepatitis, Toxic


High impact information on Hepatitis, Toxic


Chemical compound and disease context of Hepatitis, Toxic


Biological context of Hepatitis, Toxic


Anatomical context of Hepatitis, Toxic


Gene context of Hepatitis, Toxic


Analytical, diagnostic and therapeutic context of Hepatitis, Toxic


  1. Brain edema in rabbits with galactosamine-induced fulminant hepatitis. Regional differences and effects on intracranial pressure. Traber, P.G., Ganger, D.R., Blei, A.T. Gastroenterology (1986) [Pubmed]
  2. Immunohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats. Jonker, A.M., Dijkhuis, F.W., Boes, A., Hardonk, M.J., Grond, J. Hepatology (1992) [Pubmed]
  3. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma. Hann, H.W., Lee, J., Bussard, A., Liu, C., Jin, Y.R., Guha, K., Clayton, M.M., Ardlie, K., Pellini, M.J., Feitelson, M.A. Cancer Res. (2004) [Pubmed]
  4. Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine. Pineda, J.A., Larrauri, J., Macías, J., Hernández, A., Guijarro, J., Sayago, M., Gavilán, F., Aguilar, J., Lissen, E. J. Hepatol. (1999) [Pubmed]
  5. Toxic polyneuritis and toxic hepatitis related to long-term perhexiline maleate therapy. Caruzzo, C., Gaschino, n.u.l.l., Troni, W., Cremo, R. Am. Heart J. (1980) [Pubmed]
  6. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin. Henkin, Y., Johnson, K.C., Segrest, J.P. JAMA (1990) [Pubmed]
  7. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. Bourdi, M., Larrey, D., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., Guengerich, F.P., Beaune, P.H. J. Clin. Invest. (1990) [Pubmed]
  8. Icteric toxic hepatitis associated with riluzole. Castells, L.I., Gámez, J., Cervera, C., Guardia, J. Lancet (1998) [Pubmed]
  9. Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. Victorino, R.M., Maria, V.A. Lancet (1986) [Pubmed]
  10. Toxic hepatitis after therapeutic doses of benorylate and D-penicillamine. Sacher, M., Thaler, H. Lancet (1977) [Pubmed]
  11. Chronic excessive acetaminophen use and liver damage. Barker, J.D., de Carle, D.J., Anuras, S. Ann. Intern. Med. (1977) [Pubmed]
  12. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Huang, Y.S., Chern, H.D., Su, W.J., Wu, J.C., Chang, S.C., Chiang, C.H., Chang, F.Y., Lee, S.D. Hepatology (2003) [Pubmed]
  13. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Homberg, J.C., Abuaf, N., Helmy-Khalil, S., Biour, M., Poupon, R., Islam, S., Darnis, F., Levy, V.G., Opolon, P., Beaugrand, M. Hepatology (1985) [Pubmed]
  14. Antioxidant effect of Sargassum polycystum (Phaeophyceae) against acetaminophen induced changes in hepatic mitochondrial enzymes during toxic hepatitis. Balaji Raghavendran, H.R., Sathivel, A., Devaki, T. Chemosphere (2005) [Pubmed]
  15. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Grönhagen-Riska, C., Hellstrom, P.E., Fröseth, B. Am. Rev. Respir. Dis. (1978) [Pubmed]
  16. Gastric emptying in rats with acetaminophen-induced hepatitis. Hessel, G., Collares, E.F. Braz. J. Med. Biol. Res. (1998) [Pubmed]
  17. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. Robin, M.A., Le Roy, M., Descatoire, V., Pessayre, D. J. Hepatol. (1997) [Pubmed]
  18. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Huang, Y.S., Chern, H.D., Su, W.J., Wu, J.C., Lai, S.L., Yang, S.Y., Chang, F.Y., Lee, S.D. Hepatology (2002) [Pubmed]
  19. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens. Sugimura, T., Obermayer-Straub, P., Kayser, A., Braun, S., Loges, S., Alex, B., Lüttig, B., Johnson, E.F., Manns, M.P., Strassburg, C.P. Autoimmunity (2002) [Pubmed]
  20. Serum cobalt-activated acylase and gamma-glutamyl transpeptidase activities in toxic hepatitis. Szczeklik, A., Wiernikowski, A., Musial, J., Woźny, E. Gut (1975) [Pubmed]
  21. Dystonia and drug-induced hepatitis in a patient treated with clozapine. Worrall, R., Wilson, A., Cullen, M. The American journal of psychiatry. (1995) [Pubmed]
  22. Hepatitis following treatments with famotidine and then cimetidine. Hashimoto, F., Davis, R.L., Egli, D. The Annals of pharmacotherapy. (1994) [Pubmed]
  23. Dramatic increase in bilirubin after ERCP - pethidine as a possible cause of drug-induced hepatitis. Kluender, C.N., Klein, R., Kohler, B. Zeitschrift für Gastroenterologie. (2003) [Pubmed]
WikiGenes - Universities